Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04395001 · ClinicalTrials.gov registry record · Phase 4
Pain Response Evaluation of a Combined Intervention to Cope Effectively
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 280
- Enrollment target
NCT04395001: Completed Phase 4 study, sponsored by Wake Forest University Health Sciences.
NCT04395001 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 280 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04395001, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 280 participants
- Enrollment target
Study Summary
The purpose of this research is is to determine if the combination of non-opioid medication (duloxetine) and web-based pain-coping skills training (PCST) is beneficial for individuals with chronic musculoskeletal pain (CMP).
Primary Outcome
BPI score ranges from 0 to 10 with a higher score denoting a higher pain severity.
Interventions
- DRUG duloxetine
- BEHAVIORAL Web-based Cognitive Behavioral Therapy (CBT)
- OTHER Nurse-delivered Motivational Interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2024-07-18 |
| Phase | Phase 4 |
What the finished NCT04395001 record still lists
NCT04395001 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 3 interventions - of which duloxetine is the first listed.
NCT04395001 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04395001 about?
NCT04395001 is a clinical study titled "Pain Response Evaluation of a Combined Intervention to Cope Effectively". The purpose of this research is is to determine if the combination of non-opioid medication (duloxetine) and web-based pain-coping skills training (PCST) is beneficial for individuals with chronic musculoskeletal pain (CMP).
What is the current status of trial NCT04395001?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 280 participants. The study started on 2021-02-24. Estimated completion is 2024-07-18.
What interventions are being tested in trial NCT04395001?
The interventions under investigation include: duloxetine (DRUG), Web-based Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Nurse-delivered Motivational Interviewing (OTHER).
Who is sponsoring clinical trial NCT04395001?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04395001's enrollment target sits among peer trials
280 303rd of 2000 higher than 1,696 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI